Compare NRG Energy Inc (NRG) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NRG Energy Inc vs Repligen Corporation Common Stock — how do they compare? NRG Energy Inc trades at $98.41 (market cap $21.20B), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: NRG Energy Inc is the larger of the two by market cap, and NRG Energy Inc pays a 1.88% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NRG Energy Inc for 63 Days and Repligen Corporation Common Stock for 0 Days on average.
| NRG | RGEN | |
|---|---|---|
Market Cap | $21.20B | $11.31B |
Volume | 2,487,856 | 1,216,919 |
Sector | Utilities | Health |
52-Week High | $184.03 | $194.57 |
52-Week Low | $95.23 | $102.87 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | $45.15B | $11.20B |
Dividend Yield | 1.88% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NRG Energy trades at $107.18, up 0.76% on the day, with a neutral technical signal and bearish moving averages. The company reported mixed Q2 2026 earnings, missing estimates but showing strong EBITDA growth of 34% year-over-year. Recent news highlights a major 1.2 GW Texas data center power project and potential acquisition interest in a West Virginia coal plant. Analyst consensus remains strongly bullish with a $202.90 price target, though recent quarters have seen earnings misses.
The outlook is supported by strategic growth initiatives and solid cash flow, but risks include rising debt levels and execution challenges. The stock offers potential upside from analyst targets, but investors face volatility from earnings inconsistency and high leverage. The current valuation appears reasonable with a P/E of 27.91 and P/S of 0.66, balancing growth prospects with financial risk.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
